Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.
Granata V, Fusco R, Setola S, Galdiero R, Maggialetti N, Silvestro L Cancers (Basel). 2023; 15(2).
PMID: 36672301 PMC: 9857317. DOI: 10.3390/cancers15020351.
References
1.
Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R
. A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response. Int J Environ Res Public Health. 2021; 18(11).
PMC: 8197272.
DOI: 10.3390/ijerph18115592.
View
2.
Kwon J, Chung M, Park J, Lee H, Hwang H, Kang C
. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population. Acta Radiol. 2020; 62(2):164-171.
DOI: 10.1177/0284185120917118.
View
3.
Izzo F, Granata V, Fusco R, DAlessio V, Petrillo A, Lastoria S
. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. J Clin Med. 2021; 10(6).
PMC: 8005134.
DOI: 10.3390/jcm10061305.
View
4.
Yang P, Huang K, Pua U, Kim M, Li S, Li X
. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia. Eur J Surg Oncol. 2019; 46(5):811-817.
DOI: 10.1016/j.ejso.2019.12.006.
View
5.
Benedetti G, Mori M, Panzeri M, Barbera M, Palumbo D, Sini C
. CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors. Radiol Med. 2021; 126(6):745-760.
DOI: 10.1007/s11547-021-01333-z.
View